ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978

DeVita’s Appointment Reportedly On Carter’s Desk, May Be Made Official By End Of Month

May 9, 1980

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More

July 3, 1987

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998